about
Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients.Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report.Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
S768I Mutation in EGFR in Patients with Lung Cancer.
@en
S768I Mutation in EGFR in Patients with Lung Cancer.
@nl
type
label
S768I Mutation in EGFR in Patients with Lung Cancer.
@en
S768I Mutation in EGFR in Patients with Lung Cancer.
@nl
prefLabel
S768I Mutation in EGFR in Patients with Lung Cancer.
@en
S768I Mutation in EGFR in Patients with Lung Cancer.
@nl
P2093
P2860
P1476
S768I Mutation in EGFR in Patients with Lung Cancer.
@en
P2093
Aaron S Mansfield
Benjamin R Kipp
Eunhee S Yi
Jennifer L Winters
Kandelaria M Rumilla
Konstantinos Leventakos
P2860
P304
P356
10.1016/J.JTHO.2016.05.007
P577
2016-05-19T00:00:00Z